Table 2.
Reference | Cell source | Biomaterial | In vitro priming condition | Bone defect model | Highlighted results |
---|---|---|---|---|---|
Mikael et al. (2020)111 | hBMSCs | Hybrid matrix scaffolds composed of PLGA microspheres and HyA-fibrin hydrogel | 2 weeks in CHM containing TGF-β1 followed by 2 weeks in HYM | 3.5-mm calvarial defect in NSG mice | Hybrid matrix recruited host cells, leading to new bone formation and remodeling through ECO. |
Zhang et al. (2020)176 | Mouse gingiva-derived iPSCs line |
/ | 3D rotary suspension culture pellet culture; 2 weeks in CHM containing TGF-β3 and BMP-4 followed by 2 weeks in HYM | 5-mm circular calvarial defect in SD rats | The hypertrophic cartilage pellets derived from iPSCs were capable of vascularized bone regeneration via ECO in the bone defects. |
Li et al. (2019)177 | Mouse BMSCs | Ceria nanoparticle modified cancellous bones | 2 weeks in CHM containing TGF-β3 followed by 2 weeks in HYM | 3-mm femoral defect in FVB/N mice | Ceria nanoparticles significantly promoted |
ECO-based bone regeneration by ensuring sufficient hypertrophic differentiation via DHX15 activation. | |||||
Petersen et al. (2018)178 | hBMSCs | Collagen scaffold with a channel-like pore architecture | 3 weeks in CHM containing TGF-β1 followed by 2 weeks in HYM | 5-mm femoral defect in SD rats | Channel-like macroporous architecture had the potential to induce the ECO process for bone healing. |
Matsiko et al. (2018)33 | MSCs | Collagen-HyA scaffolds | 3 weeks in CHM followed by 2 weeks in HYM | 5-mm femoral defect in Fischer rats | Collagen-based scaffolds acted as suitable templates for the development of ECO constructs capable of supporting early-stage bone repair. |
Bai et al. (2018)179 | Murine BMSCs | / | Pellet culture; 2 weeks in CHM containing TGF-β3 and mangiferin followed by 2 weeks in HYM | 2-mm femoral defect in BALB/c mice | Mangiferin promoted the chondrogenic and hypertrophic differentiation of BMSCs in vitro and enhanced ECO-based bone repair in vivo. |
Dang et al. (2017)180 | hBMSCs | Gelatin microparticles loaded with TGF-β1; mineral-coated HAp microparticles loaded with BMP-2 |
Microparticle-loaded hBMSC sheets; 2 weeks in serum-free CHM followed by 3 weeks in serum-free osteogenic medium | 5-mm circular calvarial defect in athymic rats | Constructs containing microparticles loaded with TGF-β1 and BMP-2 promoted the greatest degree of healing with bony bridging via ECO. |
Bernhard et al. (2017)35 | hASCs | Decellularized bovine trabecular bone matrix | Hypertrophic chondrocyte graft: 2 weeks in CHM containing TGF-β3 and BMP-6 followed by 3 weeks in HYM; osteoblast graft: 5 weeks in osteogenic medium |
5-mm femoral defect in RUN nude rats | Hypertrophic chondrocyte grafts enhanced bone regeneration by recapitulating ECO in critical-sized orthotopic long bone defects. |
Hypertrophic chondrocyte grafts bridged 7/8 defects compared to only 1/8 for osteoblast grafts, and 3/8 for acellular scaffolds. | |||||
Thompson et al. (2016)90 | Rat BMSCs | Collagen-HyA scaffolds; | ECO constructs: 3 weeks in CHM containing TGF-β3 followed by 2 weeks in HYM; | 7-mm circular calvarial defect in Fischer rats | ECO-based constructs yielded more new bone formation within the defects than IMO-based constructs, which may be associated with VEGF secretion in the ECO-based constructs. |
collagen-HAp scaffolds | IMO constructs: 5 weeks in osteogenic medium | Collagen-HyA hypertrophic constructs supported the greatest new bone formation within the defects. | |||
Bahney et al. (2016)72 | Human OA chondrocytes | / | Pellet culture; 1 week in CHM containing TGF-β1 and BMP-4 followed by 3 weeks in CHM without growth factors | 3-mm tibial defect in immunocompromised mice | Endochondrally primed cartilage grafts generated from passaged OA chondrocytes underwent ECO, variably remodeled into woven bone, and integrated with host bone at 15/16 junctions. |
Cartilage grafts formed from primary OA chondrocytes without endochondral priming did not undergo ECO in vivo. | |||||
Cunniffe et al. (2015)181 | Rat BMSCs | Alginate hydrogels | 4 weeks in CHM containing TGF-β3 followed by 3 weeks in HYM | 5-mm femoral defect and 7-mm circular calvarial defect in Fischer rats | Chondrogenically primed BMSC-alginate constructs acted as templates to treat critical-sized defects within bones formed through either IMO or ECO. |
BMSCs, bone marrow-derived mesenchymal stem cells; CHM, chondrogenic medium; hASCs, human adipose-derived stem cells; iPSCs, induced pluripotent stem cells; HYM, hypertrophic medium; HAp, hydroxyapatite; HyA, hyaluronic acid; PEGDA, poly(ethylene glycol) diacrylate; PLGA, poly(lactide-co-glycolic) acid; GelMA, gelatin-methacrylamide; OA, osteoarthritis.
HYM is typically defined as CHM with no growth factors, with a reduced dexamethasone concentration (1–10 nM), and with β-GP (10 mM) and thyroxine (1–50 nM) or triiodothyronine (1 nM).